NCT04409561View on ClinicalTrials.gov

Reference Range for abioSCOPE® Device With the PSP Assay in a Generally Healthy Adult Population

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

November 15, 2021

Primary Completion Date

November 15, 2021

Study Completion Date

January 15, 2022

Conditions
SepsisSeptic ShockHealthy
Interventions
DEVICE

Blood collection

9 mL K3-EDTA anticoagulated venous whole blood and 9 mL lithium heparin anticoagulated venous whole blood will be collected, processed in plasma and stored until the shipment to the sponsor for PSP measurement on the abioSCOPE device with IVD CAPSULE PSP kits

Trial Locations (1)

43608

Mercy Health St. Vincent, Toledo

Sponsors

Lead Sponsor

Abionic SA
All Listed Sponsors
collaborator

Boston Biomedical Associates

OTHER

collaborator

Ocean State Clinical Coordinating Center

UNKNOWN

lead

Abionic SA

INDUSTRY

NCT04409561 - Reference Range for abioSCOPE® Device With the PSP Assay in a Generally Healthy Adult Population | Biotech Hunter | Biotech Hunter